Fertility
The World Health Organization and the American Medical Association recognize infertility as a disease that impacts one in eight Americans. Many employers are now moving toward a more comprehensive fertility and family building benefit that supports an increasingly diverse employee population and offers a more holistic approach. In fact, a recent Willis Towers Watson survey showed that 63% of employers are expected to cover fertility services beyond the diagnosis of infertility by 2022.
View Toolkit
Hemophilia
By taking a closer look at specialty drug spend related to bleeding disorders, employers may uncover significant cost savings. The Pharmacy Benefit Management Institute (PBMI) recognized this toolkit with an Excellence Award and applauded MBGH for our efforts to provide employers with education, awareness and turn-key resources to help manage the high cost of hemophilia and improve the lives of those impacted by this rare but serious disease.
View Toolkit
Ostheoarthritis
Management
According to the CDC, 54 million adults in the US have arthritis, the leading cause of work disability. The most common type of arthritis is osteoarthritis (OA), a chronic condition affecting the joints which often results in a lower quality of life due to issues with decreased mobility. Considering 60% of adults with OA are between the working ages of 18 and 64, the cost to individuals and their employers can be significant.
View Toolkit
Migraine Management
Migraine affects one in eight American adults. Prevalence peaks during prime productive years, between the ages of 25 and 55, at a time when work and family responsibilities are most significant. Although the prevalence of migraine far surpasses that of diabetes, it rarely makes the list of chronic conditions that get an employer’s attention because migraines, on the surface, appear inexpensive to treat…but that couldn’t be farther from the truth.
View Toolkit
Diabetes Management
in the Workplace
Each year over 1.5 million Americans are diagnosed with diabetes. Even more alarming is the 88 million American adults with prediabetes – and nine out of 10 don’t know they have it. Without lifestyle change, many of these individuals will go on to develop type 2 diabetes. Diabetes is an enormous economic burden for employers – both in direct medical costs and dollars lost from reduced productivity due to illness and disability.
View Toolkit
Diabetes and Cardiovascular
Disease
More than 90% of American adults with diabetes are overweight or obese and most have other symptoms that increase their risk of cardiovascular disease. Considering many adults with type 2 diabetes spend their day at the workplace, there is an opportunity for employers to put aggressive risk factor management programs in place to effectively mitigate the high medical plan costs associated with diabetes, heart disease and stroke.
View Toolkit
Addressing Pain Management
& Opioid Use/Abuse
Most employers are unaware of the direct and indirect costs associated with pain management and opioid abuse; however, the financial impact is significant. Pain related conditions affect 116 million adults in the U.S. and result in $560 - $635 billion in medical costs and lost productivity for employers. The overuse of opioids to address pain costs employers nearly twice as much in medical expenses annually compared to non-abusers.
View Toolkit
Eye Care Benefits
Most employers are unaware of the direct and indirect costs related to the eye health of their employee population. Considering the economic burden of eye disorders and vision loss ($139 billion) and one of four emergency room visits for eye problems aren’t actual emergencies, vision care should be a priority for employers. There are simple steps employers can take improve vision health while having a positive financial impact on the bottom line.
View Toolkit
Managing Specialty Drugs
Specialty drug spend represents 50% of employers’ total healthcare spend and is expected to trend up in the years ahead. Employers are in a difficult position. How do they weigh the higher costs of specialty drugs against the real potential for improved outcomes, increased productivity and enhanced quality of life for their covered populations? To make informed decisions, it's important to first understand the landscape, players, marketplace challenges and the role that specialty drugs will play now and in the future.
View Toolkit
COVID-19
MBGH is committed to keeping employers up-to-date with timely and relevant resources to help manage the ever changing landscape of COVID-19. Included in the toolkit are direct links to resources employers can use and share with their populations. Resources include: vaccine awareness videos in both English and Spanish languages, mental health links and tools, webinars from other organizations and basic links to CDC, OSHA, AEI and DOL. If you have other valuable resources to provide, please contact us. We are all in this together!
View Toolkit